China is serious about healthcare reform. New top-level guidelines will significantly reduce hospital revenue from medicine sales and promise more orders for medical equipment makers
China's policy on essential medicines will be overhauled as part of wide-ranging healthcare reforms. This may lead to the demise of many local pharmaceutical companies but opportunities in traditional Chinese medicine
China competition boost for Freshfields and ClearyFreshfields Bruckhaus Deringer is relocating one of its leading antitrust, competition and trade partners…
This is a transcript of a significant part of an interview conducted by China Law & Practice editor Phil Taylor with Yu Jianlong, vice-chairman and secretary-general of the China International Economic and Trade Arbitration Commission, on May 22 2009 in Hong Kong